US FDA Declines to Approve Growth Hormone Deficiency Treatment

The US health regulator has declined to approve the treatment for growth hormone deficiency in children that Pfizer developed with partner OPKO Health.
Reuters Health Information

source https://www.medscape.com/viewarticle/967079?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

Heart Failure Care Outside of ICU Can Lower Cost